Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers
Clinical trial NCT05696067 · COMPLETED
Trial details
- NCT number
- NCT05696067
- Sponsor
- Tatyana Zubkova
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2022-12-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.